Telomerase modulates expression of growth-controlling genes and enhances cell proliferation - PubMed (original) (raw)
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation
Laura L Smith et al. Nat Cell Biol. 2003 May.
Abstract
Most somatic cells do not express sufficient amounts of telomerase to maintain a constant telomere length during cycles of chromosome replication. Consequently, there is a limit to the number of doublings somatic cells can undergo before telomere shortening triggers an irreversible state of cellular senescence. Ectopic expression of telomerase overcomes this limitation, and in conjunction with specific oncogenes can transform cells to a tumorigenic phenotype. However, recent studies have questioned whether the stabilization of chromosome ends entirely explains the ability of telomerase to promote tumorigenesis and have resulted in the hypothesis that telomerase has a second function that also supports cell division. Here we show that ectopic expression of telomerase in human mammary epithelial cells (HMECs) results in a diminished requirement for exogenous mitogens and that this correlates with telomerase-dependent induction of genes that promote cell growth. Furthermore, we show that inhibiting expression of one of these genes, the epidermal growth factor receptor (EGFR), reverses the enhanced proliferation caused by telomerase. We conclude that telomerase may affect proliferation of epithelial cells not only by stabilizing telomeres, but also by affecting the expression of growth-promoting genes.
Similar articles
- Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
Oh BK, Lee CH, Park C, Park YN. Oh BK, et al. Exp Cell Res. 2004 Aug 15;298(2):445-54. doi: 10.1016/j.yexcr.2004.04.032. Exp Cell Res. 2004. PMID: 15265692 - Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M, Barrett JC. Oshimura M, et al. Eur J Cancer. 1997 Apr;33(5):710-5. doi: 10.1016/S0959-8049(97)00090-7. Eur J Cancer. 1997. PMID: 9282109 Review. - Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene.
Lindvall C, Hou M, Komurasaki T, Zheng C, Henriksson M, Sedivy JM, Björkholm M, Teh BT, Nordenskjöld M, Xu D. Lindvall C, et al. Cancer Res. 2003 Apr 15;63(8):1743-7. Cancer Res. 2003. PMID: 12702554 - p57KIP2 expression and loss of heterozygosity during immortal conversion of cultured human mammary epithelial cells.
Nijjar T, Wigington D, Garbe JC, Waha A, Stampfer MR, Yaswen P. Nijjar T, et al. Cancer Res. 1999 Oct 15;59(20):5112-8. Cancer Res. 1999. PMID: 10537284 - Strategies of treating cancer by cytokine regulation of chromosome end remodelling.
Liu JP, Nicholls C, Chen SM, Li H, Tao ZZ. Liu JP, et al. Clin Exp Pharmacol Physiol. 2010 Jan;37(1):88-92. doi: 10.1111/j.1440-1681.2009.05251.x. Epub 2009 Jun 29. Clin Exp Pharmacol Physiol. 2010. PMID: 19566820 Review.
Cited by
- Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes.
Plyasova AA, Zhdanov DD. Plyasova AA, et al. Biomedicines. 2021 May 9;9(5):526. doi: 10.3390/biomedicines9050526. Biomedicines. 2021. PMID: 34065134 Free PMC article. Review. - Telomerase Reverse Transcriptase and p53 Regulate Mammalian Peripheral Nervous System and CNS Axon Regeneration Downstream of c-Myc.
Ma JJ, Ju X, Xu RJ, Wang WH, Luo ZP, Liu CM, Yang L, Li B, Chen JQ, Meng B, Yang HL, Zhou FQ, Saijilafu. Ma JJ, et al. J Neurosci. 2019 Nov 13;39(46):9107-9118. doi: 10.1523/JNEUROSCI.0419-19.2019. Epub 2019 Oct 9. J Neurosci. 2019. PMID: 31597725 Free PMC article. - Telomerase and its extracurricular activities.
Jaiswal RK, Kumar P, Yadava PK. Jaiswal RK, et al. Cell Mol Biol Lett. 2013 Dec;18(4):538-54. doi: 10.2478/s11658-013-0105-0. Epub 2013 Sep 18. Cell Mol Biol Lett. 2013. PMID: 24048710 Free PMC article. Review. - Telomerase modulates Wnt signalling by association with target gene chromatin.
Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, McLaughlin M, Veenstra TD, Nusse R, McCrea PD, Artandi SE. Park JI, et al. Nature. 2009 Jul 2;460(7251):66-72. doi: 10.1038/nature08137. Nature. 2009. PMID: 19571879 Free PMC article. - TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Agarwal N, Rinaldetti S, Cheikh BB, Zhou Q, Hass EP, Jones RT, Joshi M, LaBarbera DV, Knott SRV, Cech TR, Theodorescu D. Agarwal N, et al. Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):e2102423118. doi: 10.1073/pnas.2102423118. Proc Natl Acad Sci U S A. 2021. PMID: 34518220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous